The stock price of Qiagen NV (NYSE: QGEN) has jumped by 0.23% compared to previous close of $47.85. Despite this, the company has seen a fall of -0.52% in its stock price over the last five trading days. businesswire.com reported 2025-07-08 that VENLO, Netherlands–(BUSINESS WIRE)–QIAGEN N.V. to release results for Q2 2025 and hold webcast.
Is It Worth Investing in Qiagen NV (NYSE: QGEN) Right Now?
Qiagen NV (NYSE: QGEN) has a price-to-earnings ratio of 114.90x that is above its average ratio. Additionally, the 36-month beta value for QGEN is 0.65. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 4 rating it as “overweight,” 7 rating it as “hold,” and 0 rating it as “sell.”
The public float for QGEN is 214.83M and currently, short sellers hold a 2.63% ratio of that float. The average trading volume of QGEN on July 10, 2025 was 1.43M shares.
QGEN’s Market Performance
QGEN’s stock has seen a -0.52% decrease for the week, with a 5.45% rise in the past month and a 18.98% gain in the past quarter. The volatility ratio for the week is 1.72%, and the volatility levels for the past 30 days are at 1.58% for Qiagen NV. The simple moving average for the past 20 days is 1.12% for QGEN’s stock, with a 11.12% simple moving average for the past 200 days.
Analysts’ Opinion of QGEN
Many brokerage firms have already submitted their reports for QGEN stocks, with Barclays repeating the rating for QGEN by listing it as a “Overweight.” The predicted price for QGEN in the upcoming period, according to Barclays is $55 based on the research report published on June 24, 2025 of the current year 2025.
Robert W. Baird gave a rating of “Neutral” to QGEN, setting the target price at $42 in the report published on February 19th of the current year.
QGEN Trading at 6.67% from the 50-Day Moving Average
After a stumble in the market that brought QGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -1.76% of loss for the given period.
Stock Fundamentals for QGEN
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.5 for the gross margin
The net margin for Qiagen NV stands at 0.05. The total capital return value is set at 0.02. Equity return is now at value 2.67, with 1.65 for asset returns.
Based on Qiagen NV (QGEN), the company’s capital structure generated 0.29 points at debt to capital in total, while cash flow to debt ratio is standing at 0.48. The debt to equity ratio resting at 0.41. The interest coverage ratio of the stock is 2.89.
Currently, EBITDA for the company is 368.26 million with net debt to EBITDA at 2.07. When we switch over and look at the enterprise to sales, we see a ratio of 5.57. The receivables turnover for the company is 5.88for trailing twelve months and the total asset turnover is 0.36. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.37.
Conclusion
In conclusion, Qiagen NV (QGEN) has seen better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
